These pathways are known to be involved in RB tumorigenesis and contribute to upregulation of aryl hydrocarbon receptor (AhR) signaling, estrogen-mediated S-phase entry for cancer cell proliferation, and others33–35. The gene discussed is AHR; the disease is retinoblastoma.